Amino acid deprivation induces translation of branched-chain alpha -ketoacid dehydrogenase kinase

Christopher B. Doering1 and Dean J. Danner2

2 Department of Genetics, 1 Program in Genetics and Molecular Biology, Emory University School of Medicine, Atlanta, Georgia 30322


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Leucine, isoleucine, and valine are used by cells for protein synthesis or are catabolized into sources for glucose and lipid production. These branched-chain amino acids influence proteolysis, hormone release, and cell cycle progression along with their other metabolic roles. The branched-chain amino acids play a central role in regulating cellular protein turnover by reducing autophagy. These essential amino acids are committed to their catabolic fate by the activity of the branched-chain alpha -ketoacid dehydrogenase complex. Activity of the branched-chain alpha -ketoacid dehydrogenase complex is regulated by phosphorylation/inactivation of the alpha -subunit performed by a complex specific kinase. Here we show that elimination of the branched-chain amino acids from the medium of cultured cells results in a two- to threefold increased production of the branched-chain alpha -ketoacid dehydrogenase kinase with a decrease in the activity state of the branched-chain alpha -ketoacid dehydrogenase complex. The mechanism cells use to increase kinase production under these conditions involves recruitment of the kinase mRNA into polyribosomes. Promoter activity and the steady-state concentration of the mRNA are unchanged by these conditions.

posttranscriptional regulation; polyribosomes; regulation of catabolism


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

CATABOLIC STATES, INCLUDING starvation, diabetes, infections, trauma, and cancer, all decrease plasma amino acid concentrations. In response, the body accelerates protein degradation in skeletal muscle as a means to maintain plasma amino acid concentration (36, 42). Amino acids produced from autophagy can be used directly for energy production, ketone body formation, gluconeogenesis, or new protein biosynthesis. If protein breakdown persists, a cachectic condition ensues (28, 44). Various essential amino acids have been shown to attenuate protein catabolism (39). The branched-chain amino acids (BCAA), particularly leucine, are important in controlling protein turnover in most tissues (2, 4, 22, 30, 34, 35, 42). Several roles of leucine in this process have been described. Leucine stimulates the phosphorylation of 4E-BP1, causing its release from eukaryotic initiation factor (eIF)-4E to allow formation of the eIF-4F initiation complex for protein synthesis (10). When cells are deprived of leucine, 4E-BP1 remains bound to eIF-4E and global protein synthesis decreases, whereas polyribosome fractions are diminished (10, 45). In contrast, leucine starvation results in the L-system transporter protein concentration being increased to promote uptake of extracellular leucine. The increase in transporter results from changes in translation rate (24).

Conservation of BCAA by cells is important in cell preservation. Within cells, the BCAA have two fates, incorporation into protein or irreversible degradation. Oxidative decarboxylation of the branched-chain alpha -ketoacids by branched-chain alpha -ketoacid dehydrogenase (BCKD) commits these amino acids to their catabolic fate (5). BCKD is a nuclear encoded multienzyme complex located in the mitochondria of all mammalian cells. In response to changing needs for BCAA, the activity of BCKD is regulated to conserve these essential amino acids. The activity state of BCKD is decreased when the E1alpha -subunit of the complex is phosphorylated by a complex-specific kinase (16). The activity state of BCKD is the percentage of complex that is unphosphorylated and active relative to the total amount of complex present. The amount of kinase protein present within a cell varies such that tissues with a low activity state, such as skeletal muscle, contain high levels of kinase protein. In contrast, liver and kidney contain less kinase protein and therefore maintain a high activity state of BCKD (7). When rats are fed a diet low in protein, the activity state of BCKD is decreased in liver, presumably to conserve protein (12). This response was shown to require an increase in kinase protein (41). Together, these observations suggest that activity state is not simply a balance between the specific activity of the kinase and its countering phosphatase but more a function of the amount of kinase protein present at any time. Therefore, decreases in the activity state of BCKD would necessitate an increased amount of kinase protein. To further investigate the cellular mechanisms regulating the BCKD activity state, we determined the effects of BCAA depletion on BCKD activity and BCKD kinase expression in cultured cells. Here we show that depriving cells of the BCAAs decreases the BCKD activity state with a concomitant increase in the amount of kinase protein. The latter response results from a posttranscriptional event involving enhanced recruitment of mRNA in the polyribosome fraction.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cell lines and culture conditions. Ham's F-12-K and RPMI 1640 lacking the BCAA were prepared by Atlanta Biologicals based on the GIBCO formulas. FBS was dialyzed (6,000-8,000 molecular weight cut off) against three changes of eight volumes of 1× PBS to reduce free amino acid concentrations below detectable levels (6) and was confirmed in these studies by HPLC analysis (14). When stated, individual BCAA were supplied to the depleted media at the final concentration defined for each medium (RPMI 1640: I and L at 3.8 X10-4 M, V at 1.7 × 10-4 M; F-12-K: I at 3 × 10-5 M, and L and V at 1 × 10-4 M; see Ref. 23). Rat liver cells [clone 9 (C9) from ATCC] were maintained in Ham's F-12-K medium supplemented with 10% FBS at 37°C in 5% atmospheric CO2. DG75, an EBV-negative human B cell line, and human lymphoblasts (EM280) derived by EBV transformation of human lymphocytes were maintained in RPMI 1640 supplemented with 15% FBS at 37°C in 5% atmospheric CO2. During the 5-day culture in BCAA-depleted medium, C9 cells did not have a medium change, whereas DG75 and EM280 had one change of medium after 3 days. HPLC analysis of conditioned medium from cells grown in BCAA-depleted media revealed no detectable BCAA.

Enzyme assays and Western blots. BCKD activity assays were done as previously described (32). To inhibit endogenous BCKD kinase activity and fully activate the complex, cells were incubated with 1 mM alpha -chloroisocaproate (alpha -CIC) for 10 min before initiation of activity measurements. Activity state was estimated by determining BCKD activity in the presence or absence of alpha -CIC; BCKD activity without alpha -CIC was divided by the activity in the presence of alpha -CIC and multiplied by 100. Total cellular protein and mitochondrial protein were quantified using bicinchoninic acid protein assay reagents (Pierce, Rockford, IL) following the manufacturer's protocol. Western blots with BCKD kinase specific polyclonal antiserum were done as described (7). Blot quantification was performed using an ImageQuant densitometer (Molecular Dynamics).

Nucleic acid analysis. Total RNA was isolated using Tri-Reagent (Sigma) following the manufacturer's instructions and was quantified by measuring the absorbance at 260 nm. The ratios of absorbance at 260 nm to that at 280 nm were consistently 1.7-1.9. For Northern blot analysis, 20 µg total RNA from each sample were resolved in a 1% agarose-formaldehyde gel at 80 V for 4 h. RNA was transferred to a Hybond N+ nylon membrane by capillary action overnight in 20× saline-sodium citrate (SSC). Northern blots were done as described (1) with the following modifications. Hybridization buffer contained 5× SSC, 50% formamide, 7% SDS, 5% polyethylene glycol, and 50 µg denatured salmon sperm DNA/ml. The membrane was prehybridized for 4 h at 42°C before adding the [gamma -32P]dCTP-labeled cDNA probe for overnight incubation at 42°C. The membrane was washed one time with 2× SSC and 0.5% SDS at 55°C for 20 min, two times with 0.5× SSC and 0.5% SDS at 65°C for 20 min, and one time with 0.2× SSC and 0.2% SDS at 65°C for 20 min. Hybridizing components were detected by autoradiography using Biomar Blue film (Marsh Biomedical Products, Rochester, NY). Ethidium bromide staining of the gel and hybridization using radiolabeled glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 18S rRNA as probes were performed to ensure equal loading. GAPDH has been shown previously not to change as a result of complete amino acid deprivation (17, 26).

Luciferase assay. The luciferase reporter gene assays were done in C9 cells using rat BCKD kinase promoter constructs (20) driving firefly luciferase production. Three different promoter regions were tested that contained nucleotides upstream of the AUG codon to positions -58, -128, and -449. Cells were transfected by FuGENE 6 (Boehringer Mannhiem) using a ratio of 50:1 test vector to pRL-cytomegalovirus control renilla luciferase plasmid. After 8 h in complete medium, cells were changed to fresh media either with or without the BCAA and were cultured for 4 days. Cells were harvested, and luciferase activities were measured using the Dual Luciferase Assay system (Promega) according to the manufacturer's protocol. Luminescence was determined with a Turner model TD20/20 luminometer. Firefly luciferase values were corrected for transfection efficiency by dividing by the corresponding renilla luciferase activity.

Polyribosome analysis. Preparation of polyribosomes for analysis of BCKD kinase mRNA translation was done essentially as described (9). The EM280 cell line was cultured for 5 days with or without BCAA in the medium. In an attempt to obtain similar cell numbers at the end of 5 days, only 30 × 106 cells were seeded in +BCAA medium, whereas 70 × 106 cells were seeded in -BCAA medium. At the end of 5 days, all cells were washed with 1× PBS and resuspended in fresh medium containing 100 µg cycloheximide for 15-20 min. Cells were then transferred to a buffer containing 75 mM NaCl, 4 mM MgCl2, 20 mM Tris · HCl, pH 7.5, and 0.75% Triton X-100 and were allowed to lyse for 3-5 min on ice. The solution was clarified by centrifugation at 10,000 g for 10 min, and the total supernatant was used for polyribosome fractionation. Fractionation was on a 15-45% linear gradient of sucrose in 80 mM NaCl, 10 mM Tris · HCl, pH 7.5, and 5 mM MgCl2 by centrifugation at 39,000 g for 90 min in an SW41 Ti rotor. Fractions were collected in 0.5-ml aliquots, and RNA profiles were determined by monitoring absorbance at 254 nm. Total RNA was prepared from 350 µl of each fraction using TriReagent (Sigma). The RNA was resuspended in 50 µl of 0.5% SDS and 1 mM EDTA, added to 150 µl RNA denaturing solution, and heated at 65°C for 15 min (21). Denatured RNA was loaded on a slot blot fitted with a Hybond N+ membrane. Membrane hybridization was done as for the Northern blot methods described in Nucleic acid analysis using both BCKD kinase and GAPDH as probes.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Activity state and BCAA amino acid metabolism. Cells cultured in medium lacking the BCAA respond by decreasing the activity state of the BCKD complex. This response was demonstrated with hepatocytes and lymphoblasts (Table 1). After each cell type was incubated in BCAA-depleted media for 5 days, the activity state of BCKD was reduced by at least 50% relative to the active state in the same cells cultured in complete medium. As shown for DG75 cells, this response was time dependent (Fig. 1A). Total BCKD activity in the cells grown in BCAA-depleted medium was the same as in cells in complete medium, even when cells were cultured in this medium for up to 9 days. The values of 13.4 ± 3.9 pmol CO2 · mg protein-1 · min-1 for cells grown for 9 days in the absence of BCAA and 17.7 ± 3.6 for those grown in complete medium, for this same time, were not significantly different (P = 0.325). Beyond 3 days in BCAA-free medium cell growth halts (Fig. 1B), presumably due to G1 cell cycle arrest caused by isoleucine depletion (13, 27, 48). The change in BCKD activity and growth at 5 days was not exclusively due to cell death. Trypan blue exclusion analysis showed that >75% of the cells were living (Fig. 1C), and the cells grew normally when returned to complete medium after this time (data not shown). Assuming the slight increase observed in cell death could help to replenish the depleted media with BCAA, we performed HPLC analysis on the conditioned media after the 5-day culture period (Table 2). The BCAA-deprived media contained no detectable BCAA by HPLC, whereas the control media contained BCAA concentrations similar to fresh media. HPLC also failed to detect intracellular free BCAA in these same cells cultured for 5 days in BCAA-deprived media.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Activity state of BCKD complex in cells grown 5 days in the presence or absence of branched-chain amino acids in the culture medium



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1.   A: branched-chain amino acid (BCAA) depletion affects branched-chain alpha -ketoacid (BCKD) activity state and cell growth but not cell viability. DG75 cells were cultured in RPMI 1640 media supplemented with dialyzed FBS (10%) either with (solid line and ) or without (broken line and black-triangle) the BCAA in this media. After the indicated days in culture, ~2 ×106 cells were collected and assayed for BCKD activity. The activity state values for days 3, 5, and 7 are as follows: 100, 93, 63 (+BCAA); 55, 17, 8 (-BCAA). Each data point is the mean of 3 determinations in 1 of 3 independent experiments and is representative of each. B: 10 µl of DG75 cells were removed from culture and counted at each time point using a hemocytometer. Each data point is the mean of 4 independent determinations. C: DG75 cells were cultured as above. At each time point, cells were assessed for cell viability by trypan blue exclusion analysis. Viable cells were identified by dye exclusion and divided by the number of total cells to determine percent viability. Each experiment is the mean of 4 independent determinations.


                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Concentration of BCAA in dialyzed fetal bovine serum, culture medium, and cells

Effects on BCKD kinase protein levels. During BCAA deprivation, there was an increase in the BCKD kinase protein concentration present in the mitochondria. The amount of kinase protein in EM280, DG75, and C9 cells cultured without BCAA was markedly increased over that found in cells grown in complete medium (Fig. 2A). As demonstrated with the C9 cells (Fig. 2B) by quantitative Western blot analysis (31), the kinase protein level increased two- to threefold. Deprivation of leucine alone over this same time period did not result in elevated BCKD kinase protein levels above that found in control medium (data not shown).


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 2.   Western blot for mitochondrial BCKD kinase reveals an increase in BCKD kinase upon BCAA depletion. A: lymphoblasts [DG75 and EM280 (280) cell lines] were grown in suspension culture for 5 days in media with (+) or without (-) BCAA. Mitochondrial protein (20 µg) was resolved on 10% SDS-PAGE and processed for Western blot with BCKD kinase antisera. B: C9 rat hepatocytes were treated as above for Western blot analysis. The amount of mitochondrial protein loaded on the gel is indicated at bottom. All blots were reprobed with BCKD complex antisera and were observed to contain similar levels of each subunit, attesting to equal loading of the samples (data not shown).

Measurements of promoter activity and steady-state mRNA. Synthesis of proteins depends on the sequential activity of gene transcription, RNA stability, and translation. Increased production of a protein can be the result of an altered rate of any of these processes. Two experimental approaches show that neither increased promoter activity nor RNA stability contributed to the observed increase in kinase protein. First, luciferase reporter assays with the kinase promoter driving production of luciferase showed no significant difference between cells grown in the two culture conditions (Fig. 3). BCKD kinase basal promoter activity requires only the first 58 bp upstream of the start site (21), and lengthening this to include an additional 391 bp upstream did not alter the response. Second, Northern blots also did not show an increase in steady-state mRNA concentration for the kinase transcripts between control and BCAA-deprived cells at days 1 or 5 (Fig. 4A). Densitometry quantification of data from three independent experiments consistently showed that the steady-state BCKD kinase mRNA concentration did not increase with 5 days of BCAA deprivation (Fig. 4B). In fact, a slight decrease in BCKD kinase mRNA was observed after 5 days of culture in BCAA-depleted medium compared with cells grown in complete medium. This is consistent with the finding that total RNA harvested per cell is almost 30% lower in BCAA-deprived cells vs. control cells (data not shown).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   Luciferase activity driven by the rat BCKD kinase promoter remains unchanged after BCAA depletion. Hepatocytes were transfected with a plasmid containing 1 of 3 different lengths of promoter region DNA (-449, -128, or -58) linked to the firefly luciferase reporter gene and a control renilla luciferase plasmid. Cells were maintained for 4 days in medium with (filled bars) or without (open bars) BCAA before measuring luciferase activity. Results are means ± SD of 6 independent determinations.



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 4.   Northern blot reveals no increase in BCKD kinase steady-state mRNA levels after BCAA depletion. Total RNA from C9 rat hepatocytes (20 µg) cultured for 1 or 5 days in medium with (+) or without (-) BCAA was resolved on 1% agarose and blotted to a nylon membrane. Hybridization was performed with a radiolabeled mouse BCKD kinase cDNA. Hybridization with similarly radiolabeled rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA or 18S rRNA was used to assess differences in lane loading. A: ratios of BCKD kinase to GAPDH as determined by densitometry: day 1, 0.27 (+) and 0.34 (-); day 5, 0.44 (+) and 0.13 (-). Gel is representative of 3 independent experiments. B: densitometric quantitation of BCKD kinase and 18S RNA from 3 independent experiments separate from that shown in A. The ratio of BCKD kinase RNA to 18S rRNA is shown for cells grown in medium with (filled bars) or without (open bars) BCAA for 5 days (n = 3 experiments).

Alteration of translation state. To determine if the translation rate of BCKD kinase mRNA is increased, polyribosomes were isolated from cells grown in the presence and absence of the BCAA for 5 days. The EM280 cell line was used for these experiments due to ease of culturing large cell numbers and the fact that they showed the greatest response observed by Western blot (Fig. 2A). As seen in Fig. 5A, the profiles of the polyribosome traces from each experimental condition were not substantially different except for the fact that less total RNA was present in the fractions from the BCAA-depleted cells. Hybridization to total RNA prepared from these polyribosome fractions with BCKD kinase and GAPDH-radiolabeled probes demonstrates that more of the BCKD kinase mRNA is found in the higher-order polyribosome (heptasome and larger) fractions (11-13, 15) from cells grown in the BCAA-deprived medium (Fig. 5B and Table 3). BCKD kinase transcript was not detected in fractions that did not contain ribosomes (fractions 1-4) from cells grown in either media.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 5.   Analysis of polyribosome fractions from cells grown for 5 days in the absence or presence of BCAA in the culture medium reveals increased BCKD kinase mRNA associated with higher-order polysomes. EM280 cells were cultured in the presence or absence of BCAA for 5 days. A: cells were harvested, and the cytosol was fractionated over a sucrose gradient monitored for absorbance at 254 nm (A254). B: total RNA was isolated from the resulting fractions and slot blotted to a nylon membrane with hybridization performed as in Fig. 4. Due to the small amount of RNA obtained from each fraction, all RNA obtained was loaded without quantitation. To compensate for differences in RNA content between fractions, all data are presented as the ratio of densitometry values for BCKD kinase mRNA with that for GAPDH mRNA in each fraction. Solid bars, ratios obtained when EM280 cells were grown in the presence of BCAA for 5 days; open bars, ratios when cells were grown in the absence of BCAA for 5 days. Results are representative of 3 independent experiments.


                              
View this table:
[in this window]
[in a new window]
 
Table 3.   BCKD kinase mRNA distribution among polyribosome fractions from lymphoblasts cultured 5 days in the presence or absence of BCAA

Examples of translational control often involve the nucleotide sequence and/or secondary structure of the 5'-untranslated region (UTR) of the specific mRNA (18, 37). In an attempt to assess functionality of the 5'-UTR, the cDNA for mouse BCKD kinase was engineered to contain either 107 or 21 nt of 5'-UTR along with the first 70 of 308 nt in the 3'-UTR. When the constructs were subjected to in vitro transcription/translation (TNT; Promega), the amount of immunodetectable kinase protein produced from the 107-base 5'-UTR construct was not different from the amount synthesized from the 21-base construct (data not shown).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

BCAA concentrations modulate many cellular processes, including protein synthesis, proteolysis, and hormonal responses whether measured in whole animals or cultured cells (19, 34, 38, 42). Although a wide range of cellular functions are influenced by BCAA concentration, the mechanisms that regulate the catabolism of these essential amino acids are poorly understood. To determine the effect of BCAA deprivation on BCAA degradation, we measured BCKD activity state and BCKD kinase levels in three types of cells in culture and defined the mechanism these cells used to achieve this regulation.

Marten et al. (29) examined the transcription of 19 genes in cultured hepatocytes for a response to amino acid deprivation. They found that one-third of the genes investigated responded by decreased expression, one-third showed increased expression, and one-third did not respond to the culture conditions. Other investigators have demonstrated amino acid starvation to alter translation of certain proteins (37). Observed decreases in protein synthesis result from a loss of mRNA movement into and dissociation from polyribosomes (45). These responses were observed in perfused livers and in cultured hepatocytes and Chinese hamster ovary cells (37). Further investigations attributed amino acid effects on translation to changes in the phosphorylation state of specific translation factors (15, 25, 47). Recent reports showed that leucine is the primary amino acid responsible for changing the phosphorylation state of the translational repressor 4E-BP1 and thus altering translation (10, 46). In limited cases, amino acid deprivation results in induction of specific proteins that tend to be involved in maintenance of cellular amino acid concentrations (17).

The concentration of free BCAA within a cell is a function of dietary intake, cell transport, incorporation into protein, and catabolism. Because degradation of BCAA by BCKD is an irreversible process, shifts in BCKD activity state represent the major mechanism for regulating BCAA concentration. In rats, when dietary protein or BCAA are limited, BCKD activity is suppressed (3, 8, 33). This reduction in BCKD activity has been attributed to changes in the phosphorylation state of the complex resulting from increased BCKD kinase activity. These changes occurred only after the animals were kept on the protein-deprived diet for 5-12 days. Because BCAA or protein deprivation in intact animals affects many tissues and metabolic pathways, we used cultured cells to model only the cellular response. Within cell culture, the extracellular environment is controlled easily, and single entities can be varied. Similar to the whole animal studies, we found that the maximal effect of BCAA deprivation required at least 5 days. The cells responded to these conditions by decreasing the BCKD activity state by at least 50% (Table 1). The decrease in BCKD activity state is in direct response to a two- to threefold increase in BCKD kinase protein (Fig. 2). No corresponding increase was observed for BCKD kinase steady-state mRNA levels or kinase promoter activity, as determined by luciferase reporter activity. These findings do not implicitly demonstrate that there is not some level of change in mRNA half-life or transcription rate but when taken together argue against either mechanism being substantially responsible for the response observed during the course of our study. The increase in BCKD kinase protein does appear to be the result of increased translation of the steady-state BCKD kinase mRNA, as evidenced by a shift of these transcripts into higher-order polyribosomes (Fig. 5 and Table 3). The experiments also demonstrate that, under both the control and BCAA-deprived state, all detectable BCKD kinase transcripts are bound by ribosomes. Therefore, the response is not simply a general shift of free kinase mRNA to ribosomally bound kinase mRNA but a specific change in the number of ribosomes bound to each transcript. The >20% increase in the percentage of kinase transcripts bound to higher-order polyribosomes appears to account for the two- to threefold increase in kinase protein over a 5-day period of accumulation.

Because extended times are needed to elicit the response to BCAA deprivation, it was not possible to use protein synthesis inhibitors to block the response. The prolonged times also worked against using transient transfections of the cells to study in vivo roles of the 5'- and 3'-UTR of this mRNA. Although our results approximate those measured in protein-deprived rats, the mechanism in rats was attributed to increased BCKD kinase mRNA concentration (41). This difference remains to be resolved.

The mechanism these cultured cells use to shift BCKD kinase mRNA into polyribosomes was not defined. Structural features of the 5'-UTR regions of mRNAs have been shown to play an important role in regulation of translation (18). Because the mRNA sequences for human (accession no. AF026548), rat (accession no. M93271), and mouse (accession no. AF043070) BCKD kinase are available, we performed qualitative analysis of these for potential regulatory regions. The length of each appears to be sufficient to contain information for regulation. The human 5'-UTR contains 273 nucleotides, whereas the rat and mouse have 121 and 106 bases, respectively. Sequence comparisons reveal a similarity index of 78.3 for rats and mice and a 48.5 index between rats and humans, implying conservation and importance of this region. All contain potential in-frame upstream open reading frames (uORF) and tracts of pyrimidines and can fold into secondary structures, as assessed by Lasergene software analysis (Table 4). The inclusion of uORFs has also been attributed to the instability of mRNAs, but that does not appear to be a condition observed here, since the steady-state concentration of the kinase mRNA is not changed (11). Although these putative features exist, we were not able to demonstrate a change in protein production by in vitro translation experiments using cDNA constructs with a deleted 5'-UTR compared with the full-length cDNA. The enriched environment in reticulocyte lysates for translation is likely to mask in vivo conditions.

                              
View this table:
[in this window]
[in a new window]
 
Table 4.   Characteristics of the UTR sequences in the mRNA for mammalian BCKD kinases

There are inherent properties of BCKD kinase that prohibit using standard methods to continue examination of potential mRNA regulatory sequences and to address potential changes in kinase protein turnover rates that may occur during BCAA deprivation. First, construction of a tagged kinase protein is complicated by the need for the mitochondrial targeting peptide at the amino terminal end that is lost after import into the matrix, and the carboxy terminal end of the protein contains the catalytic domain. A carboxy terminal V5-His6-tagged version of the human BCKD kinase is catalytically inactive although it is correctly imported and processed in cells that are transfected with plasmid directing its synthesis (unpublished observation). Second, the presence of BCKD kinase within all tissues containing mitochondria significantly complicates experiments involving comparisons of kinase expression from the transgene without a unique marker. To overcome this obstacle, we are currently developing a model system that is completely devoid of endogenous BCKD kinase. This system will allow direct investigation into the role of the potential regulatory regions of the BCKD kinase mRNA under various experimental conditions, including BCAA deprivation. Third, the absolute amount of BCKD kinase protein within a cell is extremely small. Estimates of the fraction of the mitochondrial protein contributed by the BCKD complex put this figure at 0.01% of total mitochondrial protein. Depending on the tissue source, <1% of this amount can be attributed to the kinase (40, 43). Conventional methods of studying protein turnover use in vivo labeling of the protein followed by immunoprecipitation and quantitation based on the fraction of radiolabel in the sample. The small percentage of total mitochondrial protein contributing to the kinase and the long time period needed for the induction of the shift into the polyribosome fraction makes experiments of this type technically difficult in design and quantitation. Therefore, we have relied on other analyses to suggest the mechanism for the observed increase in BCKD kinase, and by the process of elimination, conclude that the shift of the mRNA into the higher-order polyribosome fraction implies increased translation. It remains a possibility that the turnover rate of the kinase is slowed under the conditions of BCAA starvation and thus contributes to the observed increase in the concentration of this protein. From our studies, we can only state that increased translation is occurring and thus accounts at least in part for the observed increase in mitochondrial BCKD kinase.

A 50% decrease in BCKD activity state has a substantial effect on BCAA metabolism within these cells. By decreasing the activity state without changing total activity, the cells are effectively limiting the catabolism of BCAA to one-half of the normal rate. This may be enough to prevent substantial losses in total cellular protein in the absence of normal cellular leucine concentrations. In our study, total cellular protein did not decrease in cells grown in the absence of BCAA despite the fact that there are no detectable BCAA either inside or outside the cell. In fact, total protein harvested was slightly higher on a per cell basis in the BCAA-deprived cells (540 vs. 420 ng/cell in control cells). One possibility to account for the lack of detectable free BCAA is that all potentially free BCAA are rapidly bound as charged aminoacyl-tRNAs and are incorporated into newly synthesized proteins. Irrespective of this model, the ability of cells to adapt and retain cellular protein levels in the absence of these essential amino acids reflects the importance of BCKD regulation.


    ACKNOWLEDGEMENTS

We express gratitude to Elizabeth Jackson for technical assistance. Special thanks are also given to Dr. S. R. Price for help with the luciferase assays and editorial comments and to Dr. Y Feng for help with polyribosome analysis.


    FOOTNOTES

This work was supported by grants from the Emory University Research Committee and National Institutes of Health (NIH) Grant DK-38320. C. B. Doering was supported in part by NIH training Grant 5T32GM-08490. Lymphocyte transformations done in the Clinical Research Center at Emory University were supported by NIH Grant MO1-RR-00039.

Address for reprint requests and other correspondence: D. J. Danner, Dept. of Genetics, Emory Univ. School of Medicine, 1462 Clifton Rd., Rm. 446, Atlanta, GA 30322 (E-mail: ddanner{at}emory.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 29 February 2000; accepted in final form 7 June 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Ausubel, FM, Brent R, Kingston RE, Moore DD, Smith JA, Seidman JG, and Struhl K. Current Protocols in Molecular Biology. New York: Greene Publishing and Wiley-Interscience, 1989.

2.   Base, W, Barsigian C, Schaeffer A, Shaw E, Martinez J, and Maddrey WC. Influence of branched-chain amino acids and branched-chain keto acids on protein synthesis in isolated hepatocytes. Hepatology 7: 324-329, 1987[ISI][Medline].

3.   Beggs, M, Shaw JM, and Randle PJ. Longer-term regulation of branched-chain-2-oxoacid dehydrogenase complex studied in rat hepatocytes in culture. Biochem J 257: 271-275, 1989[ISI][Medline].

4.   Chua, B, Siehl DL, and Morgan HE. Effect of leucine and metabolites of branched chain amino acids on protein turnover in heart. J Biol Chem 254: 8358-8362, 1979[Abstract].

5.   Danner, DJ, and Doering CB. Human mutations affecting branched chain alpha -ketoacid dehydrogenase. Front Biosci 3: 517-524, 1998.

6.   Danner, DJ, and Priest JH. Branched chain ketoacid dehydrogenase activity and growth of normal and mutant human fibroblasts: the effect of branched chain amino acid concentration in culture medium. Biochem Genet 21: 895-905, 1983[ISI][Medline].

7.   Doering, CB, Coursey C, Spangler WE, and Danner DJ. Murine branched chain alpha -ketoacid dehydrogenase kinase: cDNA cloning, tissue distribution, and temperal expression during embryonic development. Gene 212: 213-219, 1998[ISI][Medline].

8.   Espinal, J, Beggs M, Patel H, and Randle PJ. Effects of low-protein diet and starvation on the activity of branched-chain 2-oxoacid dehydrogenase kinase in rat liver and heart. Biochem J 237: 285-288, 1986[ISI][Medline].

9.   Feng, Y, Absher D, Eberhart DE, Brown V, Malter HE, and Warren ST. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol Cell 1: 109-118, 1997[ISI][Medline].

10.   Fox, HL, Pham PT, Kimball SR, Jefferson LS, and Lynch CJ. Amino acid effects on translational repressor 4E-BP1 are mediated primarily by L-leucine in isolated adipocytes. Am J Physiol Cell Physiol 275: C1232-C1238, 1998[Abstract/Free Full Text].

11.   Frischmeyer, PA, and Dietz HC. Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet 8: 1893-1900, 1999[Abstract/Free Full Text].

12.   Gillim, SE, Paxton R, Cook GA, and Harris RA. Activity state of the branched chain alpha -ketoacid dehydrogenase complex in heart, liver, and kidney of normal, fasted, diabetic, and protein-starved rats. Biochem Biophys Res Commun 111: 74-81, 1983[ISI][Medline].

13.   Hamlin, JL, and Pardee AB. S phase synchrony in monolayer CHO cultures. Exp Cell Res 100: 265-275, 1976[ISI][Medline].

14.   Hara, Y, May RC, Kelly RA, and Mitch WE. Acidosis, not azotemia, stimulates branched-chain amino acid catabolism in uremic rats. Kidney Int 32: 808-814, 1987[ISI][Medline].

15.   Hara, K, Yonezawa K, Weng Q-P, Kozlowski MT, Belham C, and Avruch J. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J Biol Chem 273: 14484-14494, 1998[Abstract/Free Full Text].

16.   Harris, RA, Paxton R, Powell SM, Goodwin GW, Kuntz MJ, and Han AC. Regulation of branched-chain alpha -ketoacid dehydrogenase complex by covalent modification. Adv Enzyme Regul 25: 219-237, 1986[ISI][Medline].

17.   Heal, R, and McGivan J. Induction of calreticulin expression in response to amino acid deprivation in Chinese hamster ovary cells. Biochem J 329: 389-394, 1998[ISI][Medline].

18.   Hershey, JWB, Mathews MB, and Sonenberg N. Translational control. In: Cold Spring Harbor Monograph Series. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1996, p. 794.

19.   Hong, S-OC, and Layman DK. Effects of leucine on in vitro protein synthesis and degradation in rat skeletal muscles. J Nutr 114: 1204-1212, 1984[ISI][Medline].

20.   Huang, Y-S, and Chuang DT. Structural organization of the rat branched-chain 2-oxo acid dehydrogenase kinase gene and partial characterization of the promoter-regulatory region. Biochem J 313: 603-609, 1996[ISI][Medline].

21.   Huang, Y-S, and Chuang DT. Mechanism for basal expression of rat mitochondrial branched-chain-2-oxoacid dehydrogenase. Biochem J 334: 713-722, 1998[ISI][Medline].

22.   Hunter, DC, Weintraub M, Blackburn GL, and Bistrian BR. Branched chain amino acids as the protein component of parenteral nutrition in cancer cachexia. Br J Surg 76: 149-153, 1989[ISI][Medline].

23.   Jacoby, WB, and Pastan IH. Cell Culture. Methods Enzymol 58: 1-642, 1979.

24.   Kilberg, MS, Hutson RG, and Laine RO. Amino acid-regulated gene expression in eukaryotic cells. FASEB J 8: 13-19, 1994[Abstract/Free Full Text].

25.   Kimball, SR, and Jefferson LS. Mechanisms of translational control in liver and skeletal muscle. Biochimie 76: 729-736, 1994[ISI][Medline].

26.   Laine, RO, Shay NF, and Kilberg MS. Nuclear retention of the induced mRNA following amion acid-dependent transcriptional regulation of mammalian ribosomal proteins L17 and S25. J Biol Chem 269: 9693-9697, 1994[Abstract/Free Full Text].

27.   Ley, KD, and Tobey RA. Regulation of initiation of DNA synthesis in Chinese hamster cells. II. Induction of DNA synthesis and cell division by isoleucine and glutamine in G1-arrested cells in suspension culture. J Cell Biol 47: 453-459, 1970[Abstract/Free Full Text].

28.   Lorite, MJ, Thompson MG, Drake JL, Carling G, and Tisdale MJ. Mechanism of muscle protein degradation induced by cancer cachectic factor. Br J Cancer 78: 850-856, 1998[ISI][Medline].

29.   Marten, NW, Burke EJ, Hayden JM, and Straus DS. Effect of amino acid limitation on the expression of 19 genes in rat hepatoma cells. FASEB J 8: 538-544, 1994[Abstract/Free Full Text].

30.   May, ME, and Buse MG. Effects of branched-chain amino acids on protein turnover. Diabetes Metab Rev 5: 227-245, 1989[ISI][Medline].

31.   McConnell, BB. Formation of the Branched Chain alpha -Ketoacid Dehydrogenase Complex and Characterization of the E1beta Subunit (PhD thesis). Atlanta, GA: Emory University, 1996.

32.   McConnell, BB, Burkholder B, and Danner DJ. Two new mutations in the human E1beta subunit of branched chain alpha -ketoacid dehydrogenase associated with maple syrup urine disease. Biochim Biophys Acta 1361: 263-271, 1997[ISI][Medline].

33.   Miller, RH, Eisenstein RS, and Harper AE. Effects of dietary protein intake on branched-chain keto acid dehydrogenase activity of the rat. Immunochemical analysis of the enzyme complex. J Biol Chem 263: 3454-3461, 1988[Abstract/Free Full Text].

34.   Miotto, G, Venerando R, Khurana KK, Siliprandi N, and Mortimore GE. Control of hepatic proteolysis by leucine and isovaleryl-L-carnition through a common locus. Evidence for a possible mechanism of recognition at the plasma membrane. J Biol Chem 267: 22066-22072, 1992[Abstract/Free Full Text].

35.   Mitch, WE, and Clark AS. Specificity of the effect of leucine and its metabolites on protein degradation in skeletal muscle. Biochem J 222: 579-586, 1984[ISI][Medline].

36.   Mitch, WE, and Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 335: 1897-1905, 1996[Free Full Text].

37.   Pain, VM. Translational control during amino acid starvation. Biochimie 76: 718-728, 1994[ISI][Medline].

38.   Patti, M-E, Brambilla E, Luzi L, Landaker EJ, and Kahn CR. Bidirectional modulation of insulin action by amino acids. J Clin Invest 101: 1519-1529, 1998[Abstract/Free Full Text].

39.   Pisters, PWT, and Pearlstone DB. Protein and amino acid metabolism in cancer cachexia: investigative techniques and therapeutic interventions. Crit Rev Clin Lab Sci 30: 223-272, 1993[ISI][Medline].

40.   Popov, KM, Shimomura Y, and Harris RA. Purification and comparative study of the kinases specific for branched chain alpha -ketoacid dehydrogenase and pyruvate dehydrogenase. Protein Expr Purif 2: 278-286, 1991[Medline].

41.   Popov, KM, Zhao Y, Shimomura Y, Jaskiewicz J, Kedishvili NY, Irwin J, Goodwin GW, and Harris RA. Dietary control and tissue specific expression of branched-chain alpha -ketoacid dehydrogenase kinase. Arch Biochem Biophys 316: 148-154, 1995[ISI][Medline].

42.   Rabkin, R, Tsao T, Shi JD, and Mortimore G. Amino acids regulate kidney cell protein breakdown. J Lab Clin Med 117: 505-513, 1991[ISI][Medline].

43.   Shimomura, Y, Nanaumi N, Suzuki M, Popov KM, and Harris RA. Purification and partial characterization of branched-chain alpha -ketoacid dehydrogenase kinase from rat liver and rat heart. Arch Biochem Biophys 283: 293-299, 1990[ISI][Medline].

44.   Tisdale, MJ. Biology of cachexia. J Natl Cancer Inst 89: 1763-1773, 1997[Abstract/Free Full Text].

45.   Van Venrooij, WJW, Henshaw EC, and Hirsch CA. Nutritional effects on the poylribosome distribution and rate of protein synthesis in Ehrlich ascites tumor cells in culture. J Biol Chem 245: 5947-5953, 1970[Abstract/Free Full Text].

46.   Vary, TC, Jefferson LS, and Kimball SR. Amino acid-induced stimulation of translation initiation in rat skeletal muscle. Am J Physiol Endocrinol Metab 277: E1077-E1088, 1999[Abstract/Free Full Text].

47.   Wang, X, Campbell LE, Miller CM, and Proud CG. Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem J 334: 261-267, 1998[ISI][Medline].

48.   Wynford-Thomas, D, LaMontagne A, Marin G, and Prescott DM. Location of the isoleucine arrest point in CHO and 3T3 cells. Exp Cell Res 158: 525-532, 1985[ISI][Medline].


Am J Physiol Cell Physiol 279(5):C1587-C1594
0363-6143/00 $5.00 Copyright © 2000 the American Physiological Society